Systematic Growth Monitoring for the Early Detection of Celiac Disease in Children | Child Development | JAMA Pediatrics | JAMA Network
[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 18.207.129.82. Please contact the publisher to request reinstatement.
1.
Tanner  JM, Goldstein  H, Whitehouse  RH.  Standards for children’s height at age 2 to 9 years allowing for height of parents.  Arch Dis Child. 1970;45(244):819.PubMedGoogle ScholarCrossref
2.
Craig  D, Fayter  D, Stirk  L, Crott  R.  Growth monitoring for short stature: update of a systematic review and economic model.  Health Technol Assess. 2011;15(11):iii-iv, 1-64.PubMedGoogle ScholarCrossref
3.
Grote  FK, van Dommelen  P, Oostdijk  W,  et al.  Developing evidence-based guidelines for referral for short stature.  Arch Dis Child. 2008;93(3):212-217.PubMedGoogle ScholarCrossref
4.
van Buuren  S, van Dommelen  P, Zandwijken  GR, Grote  FK, Wit  JM, Verkerk  PH.  Towards evidence based referral criteria for growth monitoring.  Arch Dis Child. 2004;89(4):336-341.PubMedGoogle ScholarCrossref
5.
Saari  A, Sankilampi  U, Hannila  ML, Saha  MT, Mäkitie  O, Dunkel  L.  Screening of turner syndrome with novel auxological criteria facilitates early diagnosis.  J Clin Endocrinol Metab. 2012;97(11):E2125-E2132.PubMedGoogle ScholarCrossref
6.
Husby  S, Koletzko  S, Korponay-Szabó  IR,  et al; ESPGHAN Working Group on Coeliac Disease Diagnosis; ESPGHAN Gastroenterology Committee; European Society for Pediatric Gastroenterology, Hepatology, and Nutrition.  European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease.  J Pediatr Gastroenterol Nutr. 2012;54(1):136-160.PubMedGoogle ScholarCrossref
7.
Bingley  PJ, Williams  AJ, Norcross  AJ,  et al; Avon Longitudinal Study of Parents and Children Study Team.  Undiagnosed celiac disease at age seven: population based prospective birth cohort study.  BMJ. 2004;328(7435):322-323.PubMedGoogle ScholarCrossref
8.
Rosén  A, Sandström  O, Carlsson  A,  et al.  Usefulness of symptoms to screen for celiac disease.  Pediatrics. 2014;133(2):211-218.PubMedGoogle ScholarCrossref
9.
Mäki  M, Mustalahti  K, Kokkonen  J,  et al.  Prevalence of celiac disease among children in Finland.  N Engl J Med. 2003;348(25):2517-2524.PubMedGoogle ScholarCrossref
10.
Rubio-Tapia  A, Hill  ID, Kelly  CP, Calderwood  AH, Murray  JA; American College of Gastroenterology.  ACG clinical guidelines: diagnosis and management of celiac disease.  Am J Gastroenterol. 2013;108(5):656-676.PubMedGoogle ScholarCrossref
11.
Ravikumara  M, Nootigattu  VK, Sandhu  BK.  Ninety percent of celiac disease is being missed.  J Pediatr Gastroenterol Nutr. 2007;45(4):497-499.PubMedGoogle ScholarCrossref
12.
Murch  S, Jenkins  H, Auth  M,  et al; BSPGHAN.  Joint BSPGHAN and Celiac UK guidelines for the diagnosis and management of coeliac disease in children.  Arch Dis Child. 2013;98(10):806-811.PubMedGoogle ScholarCrossref
13.
Korponay-Szabó  IR, Szabados  K, Pusztai  J,  et al.  Population screening for celiac disease in primary care by district nurses using a rapid antibody test: diagnostic accuracy and feasibility study.  BMJ. 2007;335(7632):1244-1247.PubMedGoogle ScholarCrossref
14.
Fasano  A.  Should we screen for coeliac disease? yes.  BMJ. 2009;339:b3592.PubMedGoogle ScholarCrossref
15.
Evans  KE, McAllister  R, Sanders  DS.  Should we screen for coeliac disease? no.  BMJ. 2009;339:b3674.PubMedGoogle ScholarCrossref
16.
van Dommelen  P, Grote  FK, Oostdijk  W,  et al.  Screening rules for growth to detect celiac disease: a case-control simulation study.  BMC Pediatr. 2008;8:35-2431.PubMedGoogle ScholarCrossref
17.
Saari  A, Sankilampi  U, Hannila  ML, Kiviniemi  V, Kesseli  K, Dunkel  L.  New Finnish growth references for children and adolescents aged 0 to 20 years: length/height-for-age, weight-for-length/height, and body mass index-for-age.  Ann Med. 2011;43(3):235-248.PubMedGoogle ScholarCrossref
18.
Jansen  MA, Kiefte-de Jong  JC, Gaillard  R,  et al.  Growth trajectories and bone mineral density in anti-tissue transglutaminase antibody-positive children: the generation R study.  Clin Gastroenterol Hepatol. 2014:S1542-S3565.PubMedGoogle Scholar
19.
Sorva  R, Tolppanen  EM, Perheentupa  J.  Variation of growth in length and weight of children, I: years 1 and 2.  Acta Paediatr Scand. 1990;79(5):490-497.PubMedGoogle ScholarCrossref
20.
Sorva  R, Lankinen  S, Tolppanen  EM, Perheentupa  J.  Variation of growth in height and weight of children, II: after infancy.  Acta Paediatr Scand. 1990;79(5):498-506.PubMedGoogle ScholarCrossref
21.
Sorva  R, Perheentupa  J, Tolppanen  EM.  A novel format for a growth chart.  Acta Paediatr Scand. 1984;73(4):527-529.PubMedGoogle ScholarCrossref
22.
Mäki  P, Laatikainen  T, Koponen  P, Hakulinen-Viitanen  T.  The Development of Health Monitoring Among Children and the Young, LATE-Project [in Finnish]. Helsinki, Finland: Finnish National Institute for Health and Welfare: National Public Health Institute; 2008.
23.
Telega  G, Bennet  TR, Werlin  S.  Emerging new clinical patterns in the presentation of celiac disease.  Arch Pediatr Adolesc Med. 2008;162(2):164-168.PubMedGoogle ScholarCrossref
24.
Fasano  A.  Clinical presentation of celiac disease in the pediatric population.  Gastroenterology. 2005;128(4)(suppl 1):S68-S73.PubMedGoogle ScholarCrossref
25.
Steens  RF, Csizmadia  CG, George  EK, Ninaber  MK, Hira Sing  RA, Mearin  ML.  A national prospective study on childhood celiac disease in the Netherlands 1993-2000: an increasing recognition and a changing clinical picture.  J Pediatr. 2005;147(2):239-243.PubMedGoogle ScholarCrossref
26.
Garampazzi  A, Rapa  A, Mura  S,  et al.  Clinical pattern of celiac disease is still changing.  J Pediatr Gastroenterol Nutr. 2007;45(5):611-614.PubMedGoogle ScholarCrossref
27.
Meazza  C, Pagani  S, Laarej  K,  et al.  Short stature in children with celiac disease.  Pediatr Endocrinol Rev. 2009;6(4):457-463.PubMedGoogle Scholar
28.
Bonamico  M, Sciré  G, Mariani  P,  et al.  Short stature as the primary manifestation of monosymptomatic celiac disease.  J Pediatr Gastroenterol Nutr. 1992;14(1):12-16.PubMedGoogle ScholarCrossref
29.
de Lecea  A, Ribes-Koninckx  C, Polanco  I, Calvete  JF.  Serological screening (antigliadin and antiendomysium antibodies) for non-overt celiac disease in children of short stature.  Acta Paediatr Suppl. 1996;412:54-55.PubMedGoogle ScholarCrossref
30.
van Rijn  JC, Grote  FK, Oostdijk  W, Wit  JM.  Short stature and the probability of celiac disease: in the absence of gastrointestinal symptoms.  Arch Dis Child. 2004;89(9):882-883.PubMedGoogle ScholarCrossref
31.
Ludvigsson  JF, Ansved  P, Fälth-Magnusson  K,  et al.  Symptoms and signs have changed in Swedish children with celiac disease.  J Pediatr Gastroenterol Nutr. 2004;38(2):181-186.PubMedGoogle ScholarCrossref
32.
Savilahti  E, Kolho  KL, Westerholm-Ormio  M, Verkasalo  M.  Clinics of celiac disease in children in the 2000s.  Acta Paediatr. 2010;99(7):1026-1030.PubMedGoogle ScholarCrossref
33.
Saari  A, Sankilampi  U, Dunkel  L.  Multiethnic WHO growth charts may not be optimal in the screening of disorders affecting height: Turner syndrome as a model.  JAMA Pediatr. 2013;167(2):194-195.PubMedGoogle ScholarCrossref
34.
Sankilampi  U, Saari  A, Laine  T, Miettinen  PJ, Dunkel  L.  Use of electronic health records for automated screening of growth disorders in primary care.  JAMA. 2013;310(10):1071-1072.PubMedGoogle ScholarCrossref
35.
Cole  TJ.  Presenting information on growth distance and conditional velocity in one chart: practical issues of chart design.  Stat Med. 1998;17(23):2697-2707.PubMedGoogle ScholarCrossref
36.
Royston  P, Altman  DG.  Using fractional polynomials to model curved regression relationships.  Stata Tech Bull. 1994;21:11-23.Google Scholar
Original Investigation
March 2, 2015

Systematic Growth Monitoring for the Early Detection of Celiac Disease in Children

Author Affiliations
  • 1Department of Pediatrics, School of Medicine, University of Eastern Finland, Kuopio
  • 2Children’s Hospital, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
  • 3Folkhälsan Research Centre, Helsinki, Finland
  • 4Department of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden
  • 5Department of Pediatrics, Tampere University Hospital, Tampere, Finland
  • 6Centre for Endocrinology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, England
  • 7Department of Pediatrics, Kuopio University Hospital, Kuopio, Finland
JAMA Pediatr. 2015;169(3):e1525. doi:10.1001/jamapediatrics.2015.25
Abstract

Importance  Growth-monitoring programs in children aim to achieve the early detection of disorders that affect growth. Celiac disease (CD) is underdiagnosed in the pediatric population in which the presenting features often include faltering linear growth, short stature, or poor weight gain.

Objectives  To develop new evidence-based cutoffs for screening for growth disorders and to evaluate the performance of these cutoffs among children with CD measured regularly in a nationwide growth screening program.

Design, Setting, and Participants  A longitudinal retrospective study that included longitudinal growth data of healthy children (the reference population) from primary health care and children with CD (the cases) from primary health care and 3 university hospital outpatient clinics in Finland (Kuopio University Hospital, Tampere University Hospital, and Helsinki University Hospital) from January 1, 1994, to April 9, 2009. Children of the reference population were between 0 and 20 years of age and children with CD were between 1 and 16 years of age. In the reference population of 51 332 healthy children, 5 age-specific and sex-specific growth-screening parameters (height standard deviation score and body mass index standard deviation score distance from the population mean, distance from target height, change in height standard deviation score, and change in body mass index standard deviation score) were developed. Performance of these parameters and their combination was evaluated in 177 children with CD by analyzing longitudinal growth data from birth until diagnosis of CD.

Main Outcome and Measure  The screening accuracy for detecting abnormal growth in children with CD, assessed using receiver operating characteristics analysis expressed as the area under the curve.

Results  Celiac disease was detected with good accuracy (area under the curve [95% CI] = 0.88 [0.84–0.93] for girls and 0.84 [0.77–0.91] for boys) when screening was performed using the combination of all 5 growth-screening parameters. When the specificity of the screening was set at 90%, growth was already abnormal in 57% of the girls with CD and 48% of the boys with CD 2 years prior to diagnosis.

Conclusions and Relevance  Prior to diagnosis, growth faltered in most children with CD. These children could have been detected several years earlier by a well-established growth-monitoring program. Acceptable screening accuracy can be achieved for CD via the use of several growth-monitoring parameters in combination, preferably using computerized screening algorithms that are integrated into an electronic health record system.

×